Anti-UHRF1 antibody [EPR18803-11]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(13 Publications)
Rabbit Recombinant Monoclonal UHRF1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 13 publications.
View Alternative Names
ICBP90, NP95, RNF106, UHRF1, E3 ubiquitin-protein ligase UHRF1, Inverted CCAAT box-binding protein of 90 kDa, Nuclear protein 95, Nuclear zinc finger protein Np95, RING finger protein 106, RING-type E3 ubiquitin transferase UHRF1, Transcription factor ICBP90, Ubiquitin-like PHD and RING finger domain-containing protein 1, Ubiquitin-like-containing PHD and RING finger domains protein 1, HuNp95, hNp95, hUHRF1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized Jurkat (Human T cell leukemia cell line from peripheral blood) cells labeling UHRF1 with ab213223 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor®488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on HeLa cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (Goat anti-Mouse IgG (Alexa Fluor® 594)) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab213223 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling UHRF1 with ab213223 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nucleus staining on Human tonsil germinal center is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling UHRF1 with ab213223 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor®488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on HeLa cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (Goat anti-Mouse IgG (Alexa Fluor® 594)) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab213223 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed Jurkat (Human T cell leukemia cell line from peripheral blood) cells labeling UHRF1with ab213223 at 1/70 dilution (red) compared with a Rabbit IgG,monoclonal [EPR25A] - Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Immunohistochemical analysis of paraffin-embedded Human colon cancer tissue labeling UHRF1 with ab213223 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nucleus staining on Human colon cancer is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
UHRF1 was immunoprecipitated from 0.35 mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab213223 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab213223 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution
Lane 1 : HeLa whole cell lysate, 10μg (Input).
Lane 2 : ab213223 IP in HeLa whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal [EPR25A]-Isotype Control (ab172730) instead of ab213223 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-UHRF1 antibody [EPR18803-11] (ab213223)
Predicted band size: 89 kDa
false
- WB
Lab
Western blot - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. UHRF1 has two isoforms. UHRF1 undergo degradation under normal conditions as well as in response to DNA damage. (PMID : 23297342, PMID : 36593255)
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803-11] (ab213223) at 1/1000 dilution
Lane 1:
Human colon tissue lysate at 20 µg
Lane 2:
Human thymus tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution
Predicted band size: 89 kDa
false
Exposure time: 20s
- WB
Supplier Data
Western blot - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 5 seconds; Lane 3 : 30 seconds.
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803-11] (ab213223) at 1/5000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 89 kDa
Observed band size: 97 kDa
false
- WB
Lab
Western blot - Anti-UHRF1 antibody [EPR18803-11] (AB213223)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as GAPDH loading control. UHRF1 has two isoforms. UHRF1 undergo degradation under normal conditions as well as in response to DNA damage. (PMID : 23297342, PMID : 36593255)
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803-11] (ab213223) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Lane 3:
Human spleen tissue lysate at 20 µg
Lane 4:
Human colon tissue lysate at 20 µg
Lane 5:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
U-937 (Human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution
Predicted band size: 89 kDa
false
Exposure time: 20s
Related conjugates and formulations (1)
-
Anti-UHRF1 antibody [EPR18803-11] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UHRF1 engages in preserving the DNA methylation landscape ensuring proper gene expression patterns. It is part of a multi-protein complex and processes both histone modification and DNA methylation. Its presence is critical for gene silencing through the recruitment of DNMT1 and histone deacetylases. UHRF1 therefore influences regulatory regions of genes important for cell cycle progression and development.
Pathways
UHRF1 integrates into methylation-dependent gene silencing and cell cycle regulation. It actively participates in DNA damage repair pathways by modulating the p53 pathway aiding cell survival post-DNA damage. UHRF1 closely interacts with epigenetic regulators such as DNMT1 and histone deacetylases bridging methylation and chromatin remodeling to ensure proper cell cycle and transcriptional control.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Discover oncology 16:1835 PubMed41060497
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 15:e70380 PubMed40579780
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 14:153 PubMed39709438
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 26:1943-1957 PubMed39482354
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 56:1633-1643 PubMed39308302
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e18541 PubMed39046429
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastroenterology and hepatology 39:596-607 PubMed38059880
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1148611 PubMed37144221
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:106544 PubMed37123229
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20220624 PubMed36712589
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com